Zobrazeno 1 - 10
of 154
pro vyhledávání: '"M Polin"'
Autor:
K. Okoshi, M. D. M. Cezar, M. A. M. Polin, J. R. Paladino, P. F. Martinez, S. A. Oliveira, A. R. R. Lima, R. L. Damatto, S. A. R. Paiva, L. A. M. Zornoff, M. P. Okoshi
Publikováno v:
BMC Cardiovascular Disorders, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Information on the role of intermittent fasting (IF) on pathologic cardiac remodeling is scarce. We compared the effects of IF before and after myocardial infarction (MI) on rat cardiac remodeling and survival. Methods Wistar rats
Externí odkaz:
https://doaj.org/article/2fbf9962077349588371f85a662bc8af
Autor:
Elaine Huang, Michael L. Bernard, A. Elise Hiltbold, Sammy Khatib, Glenn M. Polin, Paul A. Rogers, Paari Dominic, Daniel P. Morin
Publikováno v:
Journal of Cardiovascular Electrophysiology. 33:2375-2381
Heart failure (HF) is a major cause of morbidity and mortality, with nearly half of all HF-related deaths resulting from sudden cardiac death (SCD), most often from an arrhythmic event. The pathophysiologic changes that occur in response to the hemod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51700f824c1faf8def67c00d1cb96e52
https://doi.org/10.1111/jce.15670
https://doi.org/10.1111/jce.15670
Autor:
Donald D. Chang, Peter G. Pantlin, Francis A. Benn, T. Ryan Gullatt, Michael L. Bernard, A. Elise Hiltbold, Sammy Khatib, Glenn M. Polin, Paul A. Rogers, Cruz Velasco‐Gonzalez, Daniel P. Morin
Publikováno v:
Journal of Cardiovascular Electrophysiology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cedeb5d6f3131614dbe86e14ffa30adb
https://doi.org/10.1111/jce.15913
https://doi.org/10.1111/jce.15913
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Joshua D. Aymond, Thomas Gullatt, Michael L. Bernard, Aimee E. Hiltbold, Sammy Khatib, Glenn M. Polin, Paul Rogers, Michael R. Castine, Paari Dominic, Daniel P. Morin
Publikováno v:
Heart Rhythm. 20:S69-S70
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29320929fedc9f831e5dda75c560c743
https://doi.org/10.1016/j.hrthm.2023.03.347
https://doi.org/10.1016/j.hrthm.2023.03.347
Autor:
Paul A. Rogers, Francis Benn, Glenn M. Polin, A. Elise Hiltbold, Cody M. Williams, Sammy Khatib, Michael L. Bernard, Sana M. Al-Khatib, Daniel P. Morin
Publikováno v:
Progress in Cardiovascular Diseases. 66:80-85
Atrial Fibrillation (AF) and heart failure (HF) with reduced ejection fraction (HFrEF) frequently coexist, resulting in significant morbidity and mortality. Therapeutic options for patients with AF and HFrEF are limited due to few antiarrhythmic drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30f09144d90888656246b69aeed34f40
https://doi.org/10.1016/j.pcad.2021.06.002
https://doi.org/10.1016/j.pcad.2021.06.002
Autor:
Paul A. Rogers, Sudarone Thihalolipavan, Daniel P. Morin, Ronald Chong-Yik, Sammy Khatib, Yoaav S Krauthammer, Glenn M. Polin, Michael L. Bernard
Publikováno v:
EP Europace. 22:1044-1053
Aims Evidence links markers of systemic inflammation and heart failure (HF) with ventricular arrhythmias (VA) and/or death. Biomarker levels, and the risk they indicate, may vary over time. We evaluated the utility of serial laboratory measurements o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a77e6ff0666fa3a555e7f24afba99ace
https://doi.org/10.1093/europace/euaa075
https://doi.org/10.1093/europace/euaa075
Autor:
Todd M. Rosenthal, Daniel P. Morin, Freddy M. Abi-Samra, Sammy Khatib, Paul A. Rogers, Thomas Middour, Robert M. Bober, Glenn M. Polin, Michael L. Bernard
Publikováno v:
Journal of Cardiovascular Electrophysiology. 31:1137-1146
Sudden cardiac death is a substantial cause of mortality in patients with cardiomyopathy, but evidence supporting implantable cardioverter-defibrillator (ICD) implantation is less robust in nonischemic cardiomyopathy (NICM) than in ischemic cardiomyo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c99c17c9635a283c56a9a5967586fa9a
https://doi.org/10.1111/jce.14395
https://doi.org/10.1111/jce.14395
Autor:
Michael L. Bernard, Robert M. Bober, Glenn M. Polin, Sammy Khatib, Paul A. Rogers, Daniel P. Morin, Peter G. Pantlin
Publikováno v:
Journal of Cardiovascular Electrophysiology
Background Class 1C antiarrhythmic drugs (AADs) are effective first‐line agents for atrial fibrillation (AF) treatment. However, these agents commonly are avoided in patients with known coronary artery disease (CAD), due to known increased risk in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b88c22c42618b70daf0fa48439459ad
https://doi.org/10.1111/jce.14335
https://doi.org/10.1111/jce.14335